Breast Cancer: Extracellular Matrix and Microbiome Interactions
Metadatos
Mostrar el registro completo del ítemEditorial
MDPI
Materia
breast cancer extracellular matrix microbiome
Fecha
2024-06-30Referencia bibliográfica
Herrera-Quintana, L.; Vázquez-Lorente, H.; Plaza-Diaz, J. Int. J. Mol. Sci. 2024, 25, 7226. [https://doi.org/10.3390/ijms25137226]
Resumen
Breast cancer represents the most prevalent form of cancer and the leading cause of
cancer-related mortality among females worldwide. It has been reported that several risk factors
contribute to the appearance and progression of this disease. Despite the advancements in breast
cancer treatment, a significant portion of patients with distant metastases still experiences no cure.
The extracellular matrix represents a potential target for enhanced serum biomarkers in breast cancer.
Furthermore, extracellular matrix degradation and epithelial–mesenchymal transition constitute the
primary stages of local invasion during tumorigenesis. Additionally, the microbiome has a potential
influence on diverse physiological processes. It is emerging that microbial dysbiosis is a significant
element in the development and progression of various cancers, including breast cancer. Thus,
a better understanding of extracellular matrix and microbiome interactions could provide novel
alternatives to breast cancer treatment and management. In this review, we summarize the current
evidence regarding the intricate relationship between breast cancer with the extracellular matrix and
the microbiome. We discuss the arising associations and future perspectives in this field.





